Beam Therapeutics (BEAM) EBIT Margin Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 6,993.00 |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | 7,085.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,085.00 |
| Dec 31, 2025 | 42,882.00 |
| Sep 30, 2025 | -72,970.00 |
| Jun 30, 2025 | -92,699.00 |
| Mar 31, 2025 | -69,287.00 |
| Dec 31, 2024 | -20,840.00 |
| Sep 30, 2024 | 837,994.00 |
| Jun 30, 2024 | 98.20 Mn |
| Mar 31, 2024 | 333.81 Mn |
| Dec 31, 2023 | 68.00 Mn |
| Sep 30, 2023 | 62.14 Mn |
| Jun 30, 2023 | 43.76 Mn |
| Mar 31, 2023 | 47.22 Mn |
| Dec 31, 2022 | 43.91 Mn |
| Sep 30, 2022 | 29.98 Mn |
| Jun 30, 2022 | 29.37 Mn |